Cyprotex Discovery

Founded in 1999, Cyprotex are now the largest global CRO specialising in ADME-TOX. In 2010, Cyprotex acquired the US based company Apredica, and we now have facilities in Macclesfield in the UK as well as near Boston in the US. In addition to our routine contract research business, we are continually striving to enhance existing assays and introduce new advanced technologies to our customers and we have several proprietary offerings which can only be accessed through Cyprotex.  We have the advantage of both laboratory services and in silico modelling expertise and our ultimate goal is to develop in vitro methods which can be accurately extrapolated to the in vivo situation. 

Cyprotex Discovery Limited is dedicated to high quality science, rapid turnaround and customer service excellence via expert scientists, state-of-the-art equipment and carefully designed protocols.

For more information on our services, please visit our website www.cyprotex.com